La vendita allo scoperto per WANG & LEE Group dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di WANG & LEE Group. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

WANG & LEE Group (NASDAQ:WLGS) Azioni, Report sulle vendite allo scoperto

WANG & LEE Group

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.

WANG & LEE Group Inc

The Q3 earnings report for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
The company missed on EPS by $0.0 in the previous quarter, leading to a 33.0% increase share price change the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

WOOF

Earnings Summary: Petco Health and Wellness Q3

Asana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) reported its Q3 earnings results on Thursday, December 5, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Asana beat estimated earnings by 71.0%, reporting an EPS of $-0.02 versus an estimate of $-0.07.
Revenue was up $17.38 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
The company beat on EPS by $0.03 in the previous quarter, leading to a 5.0% drop share price change the next day.
Here's a look at Asana's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.08</td>
<td>-0.08</td>
<td>-0.10</td>
<td>-0.11</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.05</td>
<td>-0.06</td>
<td>-0.04</td>
<td>-0.04</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>177.65M</td>
<td>168.73M</td>
<td>167.68M</td>
<td>164.14M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>179.21M</td>
<td>172.45M</td>
<td>171.13M</td>
<td>166.50M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Asana management provided guidance for FY 2025, expecting earnings between $-0.15 and $-0.14 per share.
To track all earnings releases for Asana <a href="https://www.benzinga.com/quote/ASAN/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASAN

Asana Earnings Analysis: Q3 Recap

WIIM

VEEV

Veeva Systems shares are trading higher after the company reported a year-over-year increase in Q3 financial results.

The earnings results for Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:05 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Tilly's missed estimated earnings by -34.0%, reporting an EPS of $-0.43 versus an estimate of $-0.32.
Revenue was down $23.03 million from the same period last year.
<h3>Historical Earnings Summary</h3>
Last quarter the company beat on EPS by $0.09 which was followed by a 4.0% drop in the share price the next day.
Here's a look at Tilly's's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.09</td>
<td>-0.47</td>
<td>-0.22</td>
<td>-0.07</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0</td>
<td>-0.48</td>
<td>-0.17</td>
<td>-0.03</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>163.81M</td>
<td>115.16M</td>
<td>171.65M</td>
<td>167.98M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>162.87M</td>
<td>115.86M</td>
<td>173.02M</td>
<td>166.47M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Tilly's management provided guidance for Q4 2024, expecting earnings between $-0.43 and $-0.32 per share.
To track all earnings releases for Tilly's <a href="https://www.benzinga.com/quote/TLYS/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TLYS

Earnings Breakdown: Tilly's Q3

News

Offerings

CYBR

CyberArk Launches Secondary Offering Of 1,142,538 Shares Ordinary Shares

Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) released its Q3 earnings on Thursday, December 5, 2024 at 04:05 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
Zumiez beat estimated earnings by 100.0%, reporting an EPS of $0.06 versus an estimate of $0.03.
Revenue was up $6.14 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
The company beat on EPS by $0.29 in the last quarter, resulting in a 4.0% increase share price change the following day.
Here's a look at Zumiez's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.33</td>
<td>-1.14</td>
<td>0.26</td>
<td>-0.18</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.04</td>
<td>-0.86</td>
<td>0.40</td>
<td>-0.12</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>201.96M</td>
<td>171.40M</td>
<td>275.87M</td>
<td>213.58M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>210.18M</td>
<td>177.39M</td>
<td>281.82M</td>
<td>216.34M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Zumiez <a href="https://www.benzinga.com/quote/ZUMZ/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ZUMZ

Zumiez: Q3 Earnings Insights

SMXT

SolarMax Technology Regains Nasdaq Compliance With $1.00 Minimum Bid Price Requirement

ULTA

Ulta Beauty shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 outlook.

Management

Unisys Announced Current President And Chief Operating Officer Mike Thomson To Succeed Peter Altabef As The Company's CEO, Effective April 1, 2025

Outbrain Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OB#NASDAQ">OB</a>) ("Outbrain"), a leading technology platform that drives business results by engaging people across the Open Internet, announced today that, at its special meeting of shareholders (the "Special Meeting") held earlier today, Outbrain shareholders voted to approve the issuance of 35 million shares of common stock and 10.5 million Series A Convertible Preferred Shares, which are convertible into common stock, in connection with the acquisition of Teads S.A. (the "Share Issuance Proposal"). The transaction remains subject to customary closing conditions, including regulatory approvals, and is expected to close during the first quarter of 2025.

Outbrain Shareholders Voted To Approve The Issuance Of 35M Shares Of Common Stock And 10.5M Series A Convertible Preferred Shares, Which Are Convertible Into Common Stock, In Connection With The Acquisition Of Teads S.A

PTEN

Patterson-UTI Reports Average Of 105 Drilling Rigs Operating In The U.S. For November 2024, Consistent With Two-Month Average Through November 30

Dividends

Owens Corning Increases Quarterly Dividend From $0.60 To $0.69

Agreement cloud company DocuSign Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) reported financial results for the third quarter Thursday after the bell. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/24/12/n42350798/docusign-announces-third-quarter-fiscal-2025-financial-results">of the report</a>.
Q3 Earnings: DocuSign reported third-quarter revenue of $754.8 million, beating the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $745.26 million. The company reported third-quarter adjusted earnings of 90 cents per share, beating analyst estimates of 87 cents per share, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue increased 8% year-over-year. Subscription revenue was up 8% year-over-year to $734.7 million and Professional services and other revenue climbed 11% to $20.1 million.
Billings came in at $752.3 million, up 9% year-over-year. Net cash from operating activities totaled $234.3 million. The company generated free cash flow of $210.7 million in the quarter. DocuSign ended the quarter with $1.1 billion in cash, cash equivalents, restricted cash and investments.
&#8220;Docusign delivered powerful new innovation for customers highlighted by new capabilities to its Intelligent Agreement Management (&#8220;IAM&#8221;) platform,&#8221; said&nbsp;Allan Thygesen, CEO of Docusign.
&#8220;In&nbsp;Q3, early IAM momentum outpaced expectations, and we continued to drive improvement in our core business with strong revenue growth and operating profit.&#8221;
Outlook: DocuSign expects fourth-quarter revenue to be in the range of $758 million to $762 million versus estimates of $755.95 million. The company sees fourth-quarter billings in the range of $870 million to $880 million.
DocuSign expects fiscal year 2025 revenue to be in the range of $2.959 billion to $2.963 billion versus estimates of $2.948 billion.
DocuSign&#8217;s management team will hold a call with analysts and investors at 5 p.m. ET to further discuss the company&#8217;s quarterly performance.
DOCU Price Action: <a href="https://www.benzinga.com/quote/DOCU" target="_blank" rel="noreferrer noopener">DocuSign shares</a> were up 17.11% in Thursday&#8217;s after-hours session, trading at $98 at the time of publication, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/24/12/42349100/gamestop-rockets-as-roaring-kitty-returns-to-x-what-does-his-tweet-signal-ahead-of-q3-earnings">GameStop Rockets As Roaring Kitty Returns To X: What Does His Tweet Signal Ahead Of Q3 Earnings?</a></li>
</ul>
Photo: Courtesy of DocuSign.

Guidance

After-Hours Center

Movers

DOCU

DocuSign Stock Soars On Q3 Earnings Beat, Revenue Beat, Strong Guidance

LULU

Lululemon Athletica shares are trading higher after the company reported better-than-expected Q3 financial results and increased its share buyback program by $1 billion.

Samsara shares are trading lower. The company reported Q3 financial results.

Cyclacel Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>, NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCCP#NASDAQ">CYCCP</a>, ", Cyclacel", or the ", Company", ))), a biopharmaceutical company developing innovative cancer medicines, today announced that it is in the process of exploring and reviewing strategic alternatives on an expedited basis in order to preserve the Company's cash, including a potential transaction with investor David Lazar of Activist Investing, LLC, which transaction would be subject to the consent of an existing securityholder.
The Company's Board of Directors is reviewing a range of appropriate strategies to realize value from its assets. The Board has directed management to reduce operating costs while such alternatives are being explored. There can be no assurance that the exploration of strategic alternatives will result in any agreement or transaction, or as to the timing of any such agreement or transaction. Further, there can be no assurance that the Company will be able to reach an agreement, or consummate a transaction, with Mr. Lazar or receive the required consent of an existing securityholder to any such transaction.
As previously disclosed, the Company does not presently meet the continued listing requirements of the Nasdaq Stock Market and its securities would be subject to delisting if the Company fails to regain compliance during the required compliance period. In the event that the Company is not able to enter into a strategic transaction and/or secure additional funding, it may be forced to cease all business operations. In such event, the Company's stockholders may lose a part or all of their investment in the Company.

CYCC

CYCCP

Cyclacel Pharmaceuticals Announces Its Exploration Of Potential Strategic Alternatives On An Expedited Basis In Order To Preserve The Company's Cash, Including A Potential Transaction With Investor David Lazar Of Activist Investing, LLC

The Q3 earnings report for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Earnings History Overview</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness Q3 Earnings Assessment

LPTH

LightPath Technologies Unveils Optical Gas Imaging Camera For Detecting Ammonia And SF6 Emissions, Offering Non-Germanium Solution Amid China's Export Ban To The U.S.

The earnings results for HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:05 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
HashiCorp beat estimated earnings by 160.0%, reporting an EPS of $0.13 versus an estimate of $0.05.
Revenue was up $27.26 million from the same period last year.
<h3>Previous Earnings Records</h3>
Last quarter the company beat on EPS by $0.08 which was followed by a 0.0% increase in the share price the next day.
Here's a look at HashiCorp's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0</td>
<td>-0.01</td>
<td>0.01</td>
<td>-0.04</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.08</td>
<td>0.05</td>
<td>0.05</td>
<td>0.03</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>157.25M</td>
<td>153.19M</td>
<td>149.29M</td>
<td>143.24M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>165.14M</td>
<td>160.58M</td>
<td>155.78M</td>
<td>146.12M</td>
</tr>
</tbody>
</table>

To track all earnings releases for HashiCorp <a href="https://www.benzinga.com/quote/HCP/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: HashiCorp Q3 Earnings

The Q3 earnings report for Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) was released on Thursday, December 5, 2024 at 04:05 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Argan beat estimated earnings by 59.0%, reporting an EPS of $2.0 versus an estimate of $1.26.
Revenue was up $93.25 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
The company beat on EPS by $0.34 in the previous quarter, leading to a 26.0% increase share price change the next day.
Here's a look at Argan's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.97</td>
<td>0.52</td>
<td>0.75</td>
<td>0.88</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.31</td>
<td>0.58</td>
<td>0.89</td>
<td>0.40</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>183.55M</td>
<td>134.75M</td>
<td>161.60M</td>
<td>162.70M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>227.01M</td>
<td>157.68M</td>
<td>164.55M</td>
<td>163.75M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Argan <a href="https://www.benzinga.com/quote/AGX/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Argan Q3 Earnings

Wang & Lee Group GAAP EPS of -$0.11, revenue of $1.44M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers that traders will want to keep an eye on Friday morning!



Moving stocks this morning are a financing deal, clinical trial data, delisting update and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>MediaCo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mdia-stock-quote/">MDIA</a>) stock is rocketing more than 80% after updating Standard General L.P.&rsquo;s <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318218278&amp;type=PDF&amp;symbol=MDIA&amp;cdn=9729acb1946a15d40e88a777455074ca&amp;companyName=Mediaco+Holding+Inc.&amp;formType=SC+13D%2FA&amp;formDescription=%5BAmend%5D+General+statement+of+acquisition+of+beneficial+ownership&amp;dateFiled=2024-04-04">stake in the company</a>.</li>



<li>DigiAsia (NASDAQ:<a href="https://investorplace.com/stock-quotes/faas-stock-quote/">FAAS</a>) shares are soaring over 79% with heavy pre-market trading.</li>



<li>Hub Cyber Security (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock is rising more than 32% after <a href="https://www.nasdaq.com/press-release/hub-cyber-security-secures-%248-million-in-financing-to-accelerate-growth-and">securing $8 million in financing</a>.</li>



<li>Grindrod Shipping (NASDAQ:<a href="https://investorplace.com/stock-quotes/grin-stock-quote/">GRIN</a>) shares are surging over 25% on a <a href="https://www.nasdaq.com/press-release/grindrod-shipping-holdings-ltd.-announces-proposed-selective-capital-reduction-2024">proposed capital reduction</a>.</li>



<li>SuperCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/spcb-stock-quote/">SPCB</a>) stock is gaining more than 15% alongside strong early morning trading.</li>



<li>Lichen China (NASDAQ:<a href="https://investorplace.com/stock-quotes/licn-stock-quote/">LICN</a>) shares are increasing close to 15% alongside <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318218306&amp;type=PDF&amp;symbol=LICN&amp;cdn=983f004ed590a25befc62d5cd9898be6&amp;companyName=Lichen+China+Limited&amp;formType=20-F&amp;formDescription=Annual+and+transition+report+of+foreign+private+issuers+%5BSections+13+or+15%28d%29%5D&amp;dateFiled=2024-04-04">a business update</a>.</li>



<li>Richtech Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rr-stock-quote/">RR</a>) stock is heading almost 15% higher without any clear news this morning.</li>



<li>Candel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cadl-stock-quote/">CADL</a>) shares are jumping over 14% on <a href="https://www.nasdaq.com/press-release/candel-therapeutics-announces-positive-interim-data-from-randomized-phase-2-clinical">positive Phase 2 study data</a>.</li>



<li>Color Star Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/add-stock-quote/">ADD</a>) stock is getting a more than 13% boost on Friday morning.</li>



<li>Wang &amp; Lee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wlgs-stock-quote/">WLGS</a>) shares are up over 12% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Semantix (NASDAQ:<a href="https://investorplace.com/stock-quotes/stix-stock-quote/">STIX</a>) stock is plummeting more than 48% <a href="https://www.nasdaq.com/press-release/semantix-announces-voluntary-delisting-from-the-nasdaq-global-market-2024-04-04">on delisting plans</a>.</li>



<li>HWH International (NASDAQ:<a href="https://investorplace.com/stock-quotes/hwh-stock-quote/">HWH</a>) shares are diving over 23% <a href="https://investorplace.com/2024/04/why-is-hwh-international-hwh-stock-up-55-today/">following a rally yesterday</a>.</li>



<li>Nutex Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/nutx-stock-quote/">NUTX</a>) stock is tumbling more than 23% on plans for a <a href="https://www.prnewswire.com/news-releases/nutex-health-announces-1-for-15-reverse-stock-split-302108960.html">reverse stock split</a>.</li>



<li>Aesthetic Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/aih-stock-quote/">AIH</a>) shares are taking a nearly 18% beating as it <a href="https://investorplace.com/2024/04/why-is-aesthetic-medical-aih-stock-up-44-today/">comes off a recent rally</a>.</li>



<li>Gamida Cell (NASDAQ:<a href="https://investorplace.com/stock-quotes/gmda-stock-quote/">GMDA</a>) stock is sliding 15% on Friday morning.</li>



<li>Reliance Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/reli-stock-quote/">RELI</a>) shares are decreasing over 12% after <a href="https://www.nasdaq.com/press-release/reliance-global-groups-revenue-grows-by-17-and-40-in-2023-compared-to-2022-and-2021">rallying yesterday on earnings data</a>.</li>



<li>Kenon (NYSE:<a href="https://investorplace.com/stock-quotes/ken-stock-quote/">KEN</a>) stock is dropping more than 11% this morning.</li>



<li>Ucommune International (NASDAQ:<a href="https://investorplace.com/stock-quotes/uk-stock-quote/">UK</a>) shares are falling over 11% today.</li>



<li>Kintara Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktra-stock-quote/">KTRA</a>) stock is declining more than 10% <a href="https://investorplace.com/2024/04/why-is-kintara-therapeutics-ktra-stock-up-103-today/">alongside volatility yesterday</a>.</li>



<li>VBI Vaccines (NASDAQ:<a href="https://investorplace.com/stock-quotes/vbiv-stock-quote/">VBIV</a>) shares close out our pre-market stock movers down over 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-april-5th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Wang & Lee Group, Inc. (WLGS) has released an update. Wang & Lee Group, Inc. reported a significant uptick in its fiscal year 2023 financials, with...

Wang & Lee Group Reports Stellar Fiscal Growth

Wang &amp; Lee Group GAAP EPS of -$0.02, revenue of $6.83M

Wang & Lee Group, Inc. (WLGS) has released an update. Wang & Lee Group, Inc. has been granted an additional 180 days, until October 21, 2024, to me...

Wang & Lee Group Granted Extension to Meet Nasdaq Requirements

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning!



Moving stocks this morning are delisting notices, an acquisition plan, a public share offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Sify Technologies Limited &ndash; Rights (NASDAQ:<a href="https://investorplace.com/stock-quotes/sifyr-stock-quote/">SIFYR</a>) are rocketing more than 49% <a href="https://www.nasdaq.com/articles/sify-technologies-sets-ads-rights-delisting-date">ahead of their delisting next week</a>.</li>



<li>Golden Heaven (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdhg-stock-quote/">GDHG</a>) stock is soaring over 47% with heavy pre-market trading.</li>



<li>Wang &amp; Lee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wlgs-stock-quote/">WLGS</a>) shares are surging close to 40% with strong early morning trading.</li>



<li>Singing Machine (NASDAQ:<a href="https://investorplace.com/stock-quotes/mics-stock-quote/">MICS</a>) stock is gaining more than 29% <a href="https://www.nasdaq.com/press-release/singing-machine-acquire-semicab-leading-ai-logistics-technology-company-2024-06-12">on acquisition news</a>.</li>



<li>Castellum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ctm-stock-quote/">CTM</a>) shares are increasing nearly 25% this morning.</li>



<li>Beamr Imaging (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmr-stock-quote/">BMR</a>) stock is rising over 23% after <a href="https://seekingalpha.com/news/4115034-beamr-imaging-product-now-on-oracle-cloud-marketplace-shares-jump-30?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain%7Csection%3Aon-the-move">adding its product</a> to a new marketplace.</li>



<li>Molecular Partners (NASDAQ:<a href="https://investorplace.com/stock-quotes/moln-stock-quote/">MOLN</a>) shares are climbing more than 16% as they continue to rise on <a href="https://www.nasdaq.com/press-release/molecular-partners-and-orano-med-share-positive-preclinical-data-their-dll3-0">positive preclinical data</a>.</li>



<li>Surf Air Mobility (NYSE:<a href="https://investorplace.com/stock-quotes/srfm-stock-quote/">SRFM</a>) stock is jumping over 15% on Wednesday morning.</li>



<li>Ocean Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/ocea-stock-quote/">OCEA</a>) shares are heading 15% higher this morning.</li>



<li>NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) stock is up more than 12% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>ThermoGenesis (NASDAQ:<a href="https://investorplace.com/stock-quotes/thmo-stock-quote/">THMO</a>) stock is plummeting over 41% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318387950&amp;type=PDF&amp;symbol=THMO&amp;cdn=c35080a0c43a3214912906647bd85f4c&amp;companyName=ThermoGenesis+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-11">on a delisting notice</a>.</li>



<li>Tonix Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnxp-stock-quote/">TNXP</a>) shares are diving almost 32% on a <a href="https://www.nasdaq.com/press-release/tonix-pharmaceuticals-announces-proposed-public-offering-2024-06-11">proposed public offering</a>.</li>



<li>U-BX Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/ubxg-stock-quote/">UBXG</a>) stock is tumbling more than 26% after rallying yesterday.</li>



<li>Clene (NASDAQ:<a href="https://investorplace.com/stock-quotes/clnn-stock-quote/">CLNN</a>) shares are taking an over 24% beating on Wednesday morning.</li>



<li>KWESST Micro Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/kwe-stock-quote/">KWE</a>) stock is sliding more than 22% <a href="https://investorplace.com/2024/06/why-is-kwesst-micro-systems-kwe-stock-up-121-today/">after rallying yesterday</a>.</li>



<li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) shares are retreating over 19% <a href="https://investorplace.com/2024/06/why-is-nauticus-robotics-kitt-stock-up-59-today/">after yesterday&rsquo;s rally</a>.</li>



<li>Blue World Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/bwaq-stock-quote/">BWAQ</a>) stock is falling more than 17% after rising higher yesterday.</li>



<li>Chanson International (NASDAQ:<a href="https://investorplace.com/stock-quotes/chsn-stock-quote/">CHSN</a>) shares are dropping over 16% this morning.</li>



<li>Mercurity Fintech (NASDAQ:<a href="https://investorplace.com/stock-quotes/mfh-stock-quote/">MFH</a>) stock is slipping more than 13% today.</li>



<li>Oblong (NASDAQ:<a href="https://investorplace.com/stock-quotes/oblg-stock-quote/">OBLG</a>) shares close out our pre-market stock movers down over 13%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-12th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We have the biggest pre-market stock movers that traders are going to want to start the week with on Monday morning!



Moving stocks this morning are Roaring Kitty news, a company filing for bankruptcy and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Loop Media (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lptv-stock-quote/">LPTV</a>) stock is rocketing 88% alongside heavy pre-market trading.</li>



<li>Golden Heaven (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdhg-stock-quote/">GDHG</a>) shares are soaring close to 43% with strong early morning trading.</li>



<li>Chewy (NYSE:<a href="https://investorplace.com/stock-quotes/chwy-stock-quote/">CHWY</a>) stock is surging almost 19% as Roaring Kitty <a href="https://www.cnbc.com/2024/07/01/chewy-shares-rally-20percent-after-sec-filing-reveals-roaring-kitty-keith-gill-has-6point6percent-stake.html">takes a stake in the company</a>.</li>



<li>Mesoblast (NASDAQ:<a href="https://investorplace.com/stock-quotes/meso-stock-quote/">MESO</a>) shares are increasing more than 16% on a <a href="https://www.nasdaq.com/press-release/mesoblast-file-biologics-license-application-ryoncilr-fda-approval-next-week-2024-07">new biologics license application</a>.</li>



<li>Barfresh Food (NASDAQ:<a href="https://investorplace.com/stock-quotes/brfh-stock-quote/">BRFH</a>) stock is rising over 16% despite a lack of news this morning.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) shares are gaining nearly 15% with strong pre-market trading.</li>



<li>Incannex Healthcare (NASDAQ:<a href="https://investorplace.com/stock-quotes/ixhl-stock-quote/">IXHL</a>) stock is climbing more than 12% without any clear news today.</li>



<li>Tempus AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/tem-stock-quote/">TEM</a>) shares are getting an over 13% boost <a href="https://www.tradingview.com/news/reuters.com,2024:newsml_L1N3IQ0UH:0-tempus-ai-rallies-in-three-day-recovery-still-below-ipo-price/">with a recent rally</a> after its initial public offering (<a href="https://investorplace.com/stock-quotes/ipo-stock-quote/">IPO</a>) last month.</li>



<li>Lion Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/lghl-stock-quote/">LGHL</a>) stock is jumping more than 13% with heavy early morning trading today.</li>



<li>Hollysys Automation Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/holi-stock-quote/">HOLI</a>) shares are up over 13% without any obvious news this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Delta Apparel (NYSEMKT:<a href="https://investorplace.com/stock-quotes/dla-stock-quote/">DLA</a>) stock is plummeting more than 34% despite no clear news this morning.</li>



<li>Chicken Soup for the Soul Entertainment (NASDAQ:<a href="https://investorplace.com/stock-quotes/csse-stock-quote/">CSSE</a>) shares are diving over 20% after <a href="https://fortune.com/2024/06/29/redbox-dvd-kiosks-chicken-soup-for-the-soul-chapter-11-bankruptcy-filing/">filing for Chapter 11 bankruptcy</a>.</li>



<li>African Agriculture (NASDAQ:<a href="https://investorplace.com/stock-quotes/aagr-stock-quote/">AAGR</a>) stock is tumbling more than 14% alongside recent volatility.</li>



<li>Chicken Soup for the Soul Entertainment (NASDAQ:<a href="https://investorplace.com/stock-quotes/cssep-stock-quote/">CSSEP</a>) shares are taking an over 14% beating with the bankruptcy filing.</li>



<li>Chicken Soup for the Soul Entertainment, Inc. &ndash; 9.50% Notes due 2025 (NASDAQ:<a href="https://investorplace.com/stock-quotes/cssen-stock-quote/">CSSEN</a>) are sliding more than 12% alongside the bankruptcy news.</li>



<li>Wang &amp; Lee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wlgs-stock-quote/">WLGS</a>) stock is falling 12% after a Friday rally.</li>



<li>Lakeside (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSH#NASDAQ">LSH</a>) shares are dropping over 10% this morning.</li>



<li>Li-Cycle (NYSE:<a href="https://investorplace.com/stock-quotes/licy-stock-quote/">LICY</a>) stock is decreasing more than 10% on an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318425152&amp;type=PDF&amp;symbol=LICY&amp;cdn=adb9d0bf10804596acf67ff3f07cb9bd&amp;companyName=Li-Cycle+Holdings+Corp.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-28">at-market sales agreement</a>.</li>



<li>AgriForce Growing Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/agri-stock-quote/">AGRI</a>) shares are slipping over 10% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318425454&amp;type=PDF&amp;symbol=AGRI&amp;cdn=5153a3d8a3670dcb6c5185b3625a84cd&amp;companyName=AgriFORCE++Growing+Systems+Ltd.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-28">a delisting notice</a>.</li>



<li>Assure (NASDAQ:<a href="https://investorplace.com/stock-quotes/ionm-stock-quote/">IONM</a>) stock closes out our pre-market stock movers down more than 10%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-1st/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Wang & Lee Group, Inc. (WLGS) has released an update. Wang & Lee Group, Inc. has announced its Annual General Meeting scheduled for October 29, 202...

Wang & Lee Group Announces 2024 AGM Agenda

Wang & Lee Group, Inc. (WLGS) has released an update. Wang & Lee Group, Inc. successfully conducted its 2024 Annual Meeting of Shareholders, where ...

Comments

WANG & LEE Group

Vendite allo scoperto

WANG & LEE Group (NASDAQ:WLGS) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO